For: | Esposito I, Konukiewitz B, Schlitter AM, Klöppel G. Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments. World J Gastroenterol 2014; 20(38): 13833-13841 [PMID: 25320520 DOI: 10.3748/wjg.v20.i38.13833] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i38/13833.htm |
Number | Citing Articles |
1 |
Friederike V. Opitz, Lena Haeberle, Alexandra Daum, Irene Esposito. Tumor Microenvironment in Pancreatic Intraepithelial Neoplasia. Cancers 2021; 13(24): 6188 doi: 10.3390/cancers13246188
|
2 |
Přemysl Frič, Jan Škrha, Aleksi Šedo, Petr Bušek, Martin Laclav, Bohuš Bunganič, Miroslav Zavoral. Precursors of pancreatic cancer. European Journal of Gastroenterology & Hepatology 2017; 29(3): e13 doi: 10.1097/MEG.0000000000000810
|
3 |
Cecilia Scandurra, Kim Björkström, Mariapia Caputo, Lucia Sarcina, Enrico Genco, Francesco Modena, Fabrizio Antonio Viola, Celestino Brunetti, Zsolt M. Kovács‐Vajna, Cinzia Di Franco, Lena Haeberle, Piero Larizza, Maria Teresa Mancini, Ronald Österbacka, William Reeves, Gaetano Scamarcio, May Wheeler, Mario Caironi, Eugenio Cantatore, Fabrizio Torricelli, Irene Esposito, Eleonora Macchia, Luisa Torsi. Analysis of Clinical Samples of Pancreatic Cyst's Lesions with A Multi‐Analyte Bioelectronic Simot Array Benchmarked Against Ultrasensitive Chemiluminescent Immunoassay. Advanced Science 2024; 11(27) doi: 10.1002/advs.202308141
|
4 |
Ari Kassardjian, Nicholas Stanzione, Hanlin L. Wang. Comparative Accuracy of Tumor Size Assessment and Stage Analysis by Imaging Modalities Versus Gross Examination for Pancreatic Ductal Adenocarcinoma. Pancreas 2019; 48(2): 223 doi: 10.1097/MPA.0000000000001233
|
5 |
|
6 |
Davide Busato, Monica Mossenta, Michele Dal Bo, Paolo Macor, Giuseppe Toffoli. The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2022; 23(18): 10279 doi: 10.3390/ijms231810279
|
7 |
Sang Hyun Choi, Hyoung Jung Kim, Kyung Won Kim, Soyeon An, Seung-Mo Hong, Song Cheol Kim, Myung-Hwan Kim. DPC4 gene expression in primary pancreatic ductal adenocarcinoma: relationship with CT characteristics. The British Journal of Radiology 2017; 90(1073): 20160403 doi: 10.1259/bjr.20160403
|
8 |
Jorge A. Roacho-Pérez, Elsa N. Garza-Treviño, Paulina Delgado-Gonzalez, Zuca G-Buentello, Juan Luis Delgado-Gallegos, Christian Chapa-Gonzalez, Margarita Sánchez-Domínguez, Celia N. Sánchez-Domínguez, Jose Francisco Islas. Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy. Life 2021; 11(11): 1187 doi: 10.3390/life11111187
|
9 |
Khadija El Jellas, Dag Hoem, Kristin G Hagen, May Britt Kalvenes, Sura Aziz, Solrun J Steine, Heike Immervoll, Stefan Johansson, Anders Molven. Associations between ABO blood groups and pancreatic ductal adenocarcinoma: influence on resection status and survival. Cancer Medicine 2017; 6(7): 1531 doi: 10.1002/cam4.1097
|
10 |
Vimal Arora, Dinesh Kumar Chellappan, Krishnan Anand, Harish Dureja. Advanced Drug Delivery Systems in the Management of Cancer. 2021; : 243 doi: 10.1016/B978-0-323-85503-7.00030-4
|
11 |
Richard T. Waldron, Aurelia Lugea, Hui-Hua Chang, Hsin-Yuan Su, Crystal Quiros, Michael S. Lewis, Mingtian Che, V. Krishnan Ramanujan, Enrique Rozengurt, Guido Eibl, Stephen J. Pandol. Upregulated Matrisomal Proteins and Extracellular Matrix Mechanosignaling Underlie Obesity-Associated Promotion of Pancreatic Ductal Adenocarcinoma. Cancers 2024; 16(8): 1593 doi: 10.3390/cancers16081593
|
12 |
Miguel A. Ortega, Laura Jiménez-Álvarez, Oscar Fraile-Martinez, Cielo Garcia-Montero, Luis G. Guijarro, Leonel Pekarek, Silvestra Barrena-Blázquez, Ángel Asúnsolo, Laura López-González, María Del Val Toledo-Lobo, Melchor Álvarez-Mon, Miguel A. Saez, Alberto Gutiérrez-Calvo, Raúl Díaz-Pedrero. Prognostic Value of Histone Acetyl Transferase 1 (HAT-1) and Inflammatory Signatures in Pancreatic Cancer. Current Issues in Molecular Biology 2024; 46(5): 3839 doi: 10.3390/cimb46050239
|
13 |
Selvaraj Jayaraman, Bhuvaneswari Ponnusamy, Ponnulakshmi Rajagopal, S. Gowtham Kumar, Kirubhanand Chandrasekar. Handbook of Animal Models and its Uses in Cancer Research. 2023; : 777 doi: 10.1007/978-981-19-3824-5_39
|
14 |
Marzieh Jamali, Erfaneh Barar, Jiaqi Shi. Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex. International Journal of Molecular Sciences 2024; 25(10): 5069 doi: 10.3390/ijms25105069
|
15 |
Günter Klöppel, Irene Esposito, Atsuko Kasajima, Björn Konukiewitz, Jutta Lüttges, Bence Sipos. Pathologie. Pathologie 2020; : 707 doi: 10.1007/978-3-642-04557-8_24
|
16 |
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Pathology of the Pancreas. Encyclopedia of Pathology 2022; : 130 doi: 10.1007/978-3-030-62416-3_5572
|
17 |
|
18 |
Xuan-Dung Ho, Manh-Hung Vuong, Khanh-Luan Tran, Hoang-Quy Nguyen, Quang-Trung Tran. Treatment Landscape of Targeted Therapies in Oncology. 2023; : 183 doi: 10.1016/B978-0-443-16034-9.00007-1
|
19 |
Rita Rebelo, Bárbara Polónia, Lúcio Lara Santos, M. Helena Vasconcelos, Cristina P. R. Xavier. Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma. Pharmaceuticals 2021; 14(3): 280 doi: 10.3390/ph14030280
|
20 |
|
21 |
Sanghamitra Saha. Periampullary cancers: Role of the radiologist. Annals of Oncology Research and Therapy 2025; 5(1): 3 doi: 10.4103/aort.aort_26_24
|
22 |
Carl Stephan Leonhardt, Willem Niesen, Eva Kalkum, Rosa Klotz, Thomas Hank, Markus Wolfgang Büchler, Oliver Strobel, Pascal Probst. Prognostic relevance of the revised R status definition in pancreatic cancer: meta-analysis. BJS Open 2022; 6(2) doi: 10.1093/bjsopen/zrac010
|
23 |
Othman Saleh, Hani Shihadeh, Ahmad Yousef, Hana Erekat, Fatima Abdallh, Ahmad Al-leimon, Rawan Elsalhy, Abdalrahman Altiti, Majd Dajani, Majd M. AlBarakat. The Effect of Intratumor Heterogeneity in Pancreatic Ductal Adenocarcinoma Progression and Treatment. Pancreas 2024; 53(5): e450 doi: 10.1097/MPA.0000000000002342
|
24 |
Sukhwinder Kaur, Maneesh Jain, Surinder K. Batra. Liquid Biopsy for Identification of High-Risk Cystic Lesions of Pancreas. Gastroenterology 2021; 160(4): 1016 doi: 10.1053/j.gastro.2020.12.039
|
25 |
Tobias Piegeler, Thomas Winder, Sabine Kern, Bernhard Pestalozzi, Paul Magnus Schneider, Beatrice Beck-Schimmer. Detection of circulating tumor cells in patients with esophagogastric or pancreatic adenocarcinoma using the CellSearch® system: An observational feasibility study. Oncology Letters 2016; 12(2): 1513 doi: 10.3892/ol.2016.4809
|
26 |
Qi Zhou, Xufeng Tao, Shilin Xia, Fangyue Guo, Chen Pan, Hong Xiang, Dong Shang. T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00382
|
27 |
Enrica Saponara, Michele Visentin, Francesco Baschieri, Gitta Seleznik, Paola Martinelli, Irene Esposito, Johanna Buschmann, Rong Chen, Rossella Parrotta, Nathalie Borgeaud, Marta Bombardo, Ermanno Malagola, Amedeo Caflisch, Hesso Farhan, Rolf Graf, Sabrina Sonda. Serotonin uptake is required for Rac1 activation in Kras‐induced acinar‐to‐ductal metaplasia in the pancreas. The Journal of Pathology 2018; 246(3): 352 doi: 10.1002/path.5147
|
28 |
Joseph Carmicheal, Asish Patel, Vipin Dalal, Pranita Atri, Amaninder S. Dhaliwal, Uwe A. Wittel, Mokenge P. Malafa, Geoffrey Talmon, Benjamin J. Swanson, Shailender Singh, Maneesh Jain, Sukhwinder Kaur, Surinder K. Batra. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1873(1): 188318 doi: 10.1016/j.bbcan.2019.188318
|
29 |
Selvaraj Jayaraman, Bhuvaneswari Ponnusamy, Ponnulakshmi Rajagopal, S. Gowtham Kumar, Kirubhanand Chandrasekar. Handbook of Animal Models and its Uses in Cancer Research. 2022; : 1 doi: 10.1007/978-981-19-1282-5_39-1
|
30 |
Mirella Giordano, Andrea Cacciato Insilla, Daniela Campani. Encyclopedia of Pathology. Encyclopedia of Pathology 2021; : 1 doi: 10.1007/978-3-319-28845-1_5533-1
|
31 |
Anusha Ande, Maher Chaar, Sihem Ait-Oudhia. Multiscale systems pharmacological analysis of everolimus action in hepatocellular carcinoma. Journal of Pharmacokinetics and Pharmacodynamics 2018; 45(4): 607 doi: 10.1007/s10928-018-9590-0
|
32 |
Liya Huang, Ting Ye, Jingjing Wang, Xiaojing Gu, Ruiting Ma, Lulu Sheng, Binwu Ma. Identification of Survival-Associated Hub Genes in Pancreatic Adenocarcinoma Based on WGCNA. Frontiers in Genetics 2022; 12 doi: 10.3389/fgene.2021.814798
|
33 |
Andrew McGuigan, Paul Kelly, Richard C Turkington, Claire Jones, Helen G Coleman, R Stephen McCain. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World Journal of Gastroenterology 2018; 24(43): 4846-4861 doi: 10.3748/wjg.v24.i43.4846
|
34 |
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Encyclopedia of Pathology. Encyclopedia of Pathology 2021; : 1 doi: 10.1007/978-3-319-28845-1_5573-1
|
35 |
Marta Cáceres, Rita Quesada, Mar Iglesias, Francisco X. Real, Maria Villamonte, Jaime Martinez de Villarreal, Mónica Pérez, Ana Andaluz, Xavier Moll, Enrique Berjano, Dimitri Dorcaratto, Patricia Sánchez-Velázquez, Luís Grande, Fernando Burdío. Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-74947-4
|
36 |
Aditi Kothari, Matthew J. Flick. Coagulation Signaling through PAR1 as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma. International Journal of Molecular Sciences 2021; 22(10): 5138 doi: 10.3390/ijms22105138
|
37 |
Mohamed Badheeb, Adham Abdelrahim, Abdullah Esmail, Godsfavour Umoru, Karen Abboud, Ebtesam Al-Najjar, Ghaith Rasheed, Mohammed Alkhulaifawi, Ala Abudayyeh, Maen Abdelrahim. Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening. Current Oncology 2022; 29(11): 8693 doi: 10.3390/curroncol29110686
|
38 |
Tasvi Daya, Andrea Breytenbach, Liang Gu, Mandeep Kaur. Cholesterol metabolism in pancreatic cancer and associated therapeutic strategies. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2025; 1870(2): 159578 doi: 10.1016/j.bbalip.2024.159578
|
39 |
Mirella Giordano, Andrea Cacciato Insilla, Daniela Campani. Pathology of the Pancreas. Encyclopedia of Pathology 2022; : 136 doi: 10.1007/978-3-030-62416-3_5533
|
40 |
Kelly E. Diaz, Aimee L. Lucas. Familial Pancreatic Ductal Adenocarcinoma. The American Journal of Pathology 2019; 189(1): 36 doi: 10.1016/j.ajpath.2018.06.026
|
41 |
Haidi Chen, Qifeng Zhuo, Zeng Ye, Xiaowu Xu, Shunrong Ji. Organoid model: A new hope for pancreatic cancer treatment?. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1875(1): 188466 doi: 10.1016/j.bbcan.2020.188466
|
42 |
Kanan Panchal, Rakesh Kumar Sahoo, Umesh Gupta, Akash Chaurasiya. Role of targeted immunotherapy for pancreatic ductal adenocarcinoma (PDAC) treatment: An overview. International Immunopharmacology 2021; 95: 107508 doi: 10.1016/j.intimp.2021.107508
|
43 |
Mark J. Hoenerhoff, Arun Kumar R. Pandiri. Toxicologic Pathology for Non-Pathologists. 2019; : 137 doi: 10.1007/978-1-4939-9777-0_5
|
44 |
John C. Chang, Madappa Kundranda. Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma. International Journal of Molecular Sciences 2017; 18(3): 667 doi: 10.3390/ijms18030667
|
45 |
Björn Konukiewitz, Moritz Jesinghaus, Atsuko Kasajima, Günter Klöppel. Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls. Virchows Archiv 2022; 480(2): 247 doi: 10.1007/s00428-021-03211-5
|
46 |
Miguel A. Ortega, Oscar Fraile-Martinez, Leonel Pekarek, Cielo García-Montero, Miguel Angel Alvarez-Mon, Alejandro J. Castellanos, Natalio García-Honduvilla, Julia Buján, Melchor Alvarez-Mon, Miguel A. Sáez, Luis G. Guijarro, Angel Asúnsolo. Oxidative Stress Markers Are Associated with a Poor Prognosis in Patients with Pancreatic Cancer. Antioxidants 2022; 11(4): 759 doi: 10.3390/antiox11040759
|
47 |
Xiao Wang, Wenbin Kuang, Jiayu Ding, Jiaxing Li, Minghui Ji, Weijiao Chen, Hao Shen, Zhongrui Shi, Dawei Wang, Liping Wang, Peng Yang. Systematic Identification of the RNA-Binding Protein STAU2 as a Key Regulator of Pancreatic Adenocarcinoma. Cancers 2022; 14(15): 3629 doi: 10.3390/cancers14153629
|
48 |
Cielo García-Montero, Oscar Fraile-Martinez, David Cobo-Prieto, Diego De Leon-Oliva, Diego Liviu Boaru, Patricia De Castro-Martinez, Leonel Pekarek, Raquel Gragera, Mauricio Hernández-Fernández, Luis G. Guijarro, María Del Val Toledo-Lobo, Laura López-González, Raul Díaz-Pedrero, Jorge Monserrat, Melchor Álvarez-Mon, Miguel A. Saez, Miguel A. Ortega. Abnormal Histopathological Expression of Klotho, Ferroptosis, and Circadian Clock Regulators in Pancreatic Ductal Adenocarcinoma: Prognostic Implications and Correlation Analyses. Biomolecules 2024; 14(8): 947 doi: 10.3390/biom14080947
|
49 |
Chanjuan Shi, Fong Cheng Pan, Jessica N. Kim, M. Kay Washington, Chandrasekhar Padmanabhan, Christian T. Meyer, Janel L. Kopp, Maike Sander, Maureen Gannon, R. Daniel Beauchamp, Christopher V. Wright, Anna L. Means. Differential Cell Susceptibilities to Kras in the Setting of Obstructive Chronic Pancreatitis. Cellular and Molecular Gastroenterology and Hepatology 2019; 8(4): 579 doi: 10.1016/j.jcmgh.2019.07.001
|
50 |
Guillermo Urrutia, Thiago Milech de Assuncao, Angela J. Mathison, Ann Salmonson, Romica Kerketta, Atefeh Zeighami, Timothy J. Stodola, Volkan Adsay, Burcin Pehlivanoglu, Michael B. Dwinell, Michael T. Zimmermann, Juan L. Iovanna, Raul Urrutia, Gwen Lomberk. Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression Networks. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.681153
|
51 |
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Pathology of the Pancreas. Encyclopedia of Pathology 2022; : 132 doi: 10.1007/978-3-030-62416-3_5573
|
52 |
Abdullah Esmail, Mohamed Badheeb, Maen Abdelrahim. Pancreatic Cancer- Updates in Pathogenesis, Diagnosis and Therapies. 2023; doi: 10.5772/intechopen.110887
|
53 |
M. Ducreux, A. Sa. Cuhna, C. Caramella, A. Hollebecque, P. Burtin, D. Goéré, T. Seufferlein, K. Haustermans, J.L. Van Laethem, T. Conroy, D. Arnold. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology 2015; 26: v56 doi: 10.1093/annonc/mdv295
|
54 |
Michael Friberg Bruun Nielsen, Michael Bau Mortensen, Sönke Detlefsen. Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells. World Journal of Gastroenterology 2016; 22(9): 2678-2700 doi: 10.3748/wjg.v22.i9.2678
|
55 |
Anna Melissa Schlitter, Björn Konukiewitz, Atsuko Kasajima, Maximilian Reichert, Günter Klöppel. Das duktale Adenokarzinom des Pankreas: Subtypen und Molekularpathologie. Der Pathologe 2021; 42(5): 464 doi: 10.1007/s00292-021-00965-2
|
56 |
Miguel A. Ortega, Leonel Pekarek, Oscar Fraile-Martinez, Cielo Garcia-Montero, Miguel A. Saez, Angel Asúnsolo, Miguel A. Alvarez-Mon, Jorge Monserrat, Lidia Ruiz-Llorente, Natalio García-Honduvilla, Agustin Albillos, Julia Buján, Melchor Alvarez-Mon, Luis G. Guijarro. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies. Current Oncology 2022; 29(4): 2442 doi: 10.3390/curroncol29040198
|
57 |
Anna Melissa Schlitter, Angela Segler, Katja Steiger, Christoph W. Michalski, Carsten Jäger, Björn Konukiewitz, Nicole Pfarr, Volker Endris, Markus Bettstetter, Bo Kong, Ivonne Regel, Jörg Kleeff, Günter Klöppel, Irene Esposito. Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes. Scientific Reports 2017; 7(1) doi: 10.1038/srep41064
|
58 |
Diana Pinkert-Leetsch, Jasper Frohn, Philipp Ströbel, Frauke Alves, Tim Salditt, Jeannine Missbach-Guentner. Three-dimensional analysis of human pancreatic cancer specimens by phase-contrast based X-ray tomography – the next dimension of diagnosis. Cancer Imaging 2023; 23(1) doi: 10.1186/s40644-023-00559-6
|
59 |
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Encyclopedia of Pathology. Encyclopedia of Pathology 2021; : 1 doi: 10.1007/978-3-319-28845-1_5574-1
|
60 |
Fatemeh Abbaszadeh, Sajad Fakhri, Sana Piri, Haroon Khan. Phytonutrients in the Treatment of Gastrointestinal Cancer. 2023; : 1 doi: 10.2174/9789815049633123010004
|
61 |
Zhaoyan Qiu, Yi Chu, Bing Xu, Qian Wang, Mingzuo Jiang, Xiaowei Li, Gang Wang, Pengfei Yu, Guoxiao Liu, Hua Wang, Huijie Kang, Jiayu Liu, Yu Zhang, Jian-Ping Jin, Kaichun Wu, Jie Liang. Increased expression of calponin 2 is a positive prognostic factor in pancreatic ductal adenocarcinoma. Oncotarget 2017; 8(34): 56428 doi: 10.18632/oncotarget.17701
|
62 |
Yusuke Fujita, Minoru Kitago, Yohei Masugi, Osamu Itano, Masahiro Shinoda, Yuta Abe, Taizo Hibi, Hiroshi Yagi, Yoko Fujii-Nishimura, Michiie Sakamoto, Yuko Kitagawa. Two cases of pancreatic ductal adenocarcinoma with intrapancreatic metastasis. World Journal of Gastroenterology 2016; 22(41): 9222-9228 doi: 10.3748/wjg.v22.i41.9222
|
63 |
Jia Yao, Man Yang, Lawrence Atteh, Pinyan Liu, Yongcui Mao, Wenbo Meng, Xun Li. A pancreas tumor derived organoid study: from drug screen to precision medicine. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02044-1
|
64 |
Linying Chen, Xiao Xu, Xinxin Wen, Shenmin Xu, Long Wang, Wenxian Lu, Mingting Jiang, Jing Huang, Dayun Yang, Jichuang Wang, Min Zheng, Xiao Zhen Zhou, Kun Ping Lu, Hekun Liu. Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis. Cancer Science 2019; 110(8): 2442 doi: 10.1111/cas.14085
|
65 |
Linning E, Yan Xu, Zhifeng Wu, Li Li, Na Zhang, Hao Yang, Lawrence H. Schwartz, Lin Lu, Binsheng Zhao. Differentiation of Focal-Type Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma Using Radiomics Based on Multiphasic Computed Tomography. Journal of Computer Assisted Tomography 2020; 44(4): 511 doi: 10.1097/RCT.0000000000001049
|
66 |
S Roshni, AL Lijeesh, J Jose, A Mathew. Evaluation of Treatment Outcome and Acute Toxicity in Patients Undergoing Adjuvant Therapy in Ductal Carcinoma Pancreas: A Prospective Observational Study. EMJ Oncology 2021; : 72 doi: 10.33590/emjoncol/21-00018
|
67 |
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Pathology of the Pancreas. Encyclopedia of Pathology 2022; : 126 doi: 10.1007/978-3-030-62416-3_5574
|
68 |
Leticia Moreira, Basil Bakir, Priya Chatterji, Zahra Dantes, Maximilian Reichert, Anil K. Rustgi. Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer. Cellular and Molecular Gastroenterology and Hepatology 2018; 5(3): 289 doi: 10.1016/j.jcmgh.2017.12.004
|
69 |
Glancis Luzeena Raja Arul, Merih D. Toruner, Robert A. Gatenby, Ryan M. Carr. Ecoevolutionary biology of pancreatic ductal adenocarcinoma. Pancreatology 2022; 22(6): 730 doi: 10.1016/j.pan.2022.06.005
|
70 |
Andrea Cacciato Insilla, Mirella Giordano, Daniela Campani. Encyclopedia of Pathology. Encyclopedia of Pathology 2021; : 1 doi: 10.1007/978-3-319-28845-1_5572-1
|
71 |
Debasmita Dutta, Priyanka Ray, Archana De, Arnab Ghosh, Raj Shankar Hazra, Pratyusha Ghosh, Snigdha Banerjee, Francisco J. Diaz, Sunil P. Upadhyay, Mohiuddin Quadir, Sushanta K. Banerjee, Pankaj K. Singh. pH-responsive targeted nanoparticles release ERK-inhibitor in the hypoxic zone and sensitize free gemcitabine in mutant K-Ras-addicted pancreatic cancer cells and mouse model. PLOS ONE 2024; 19(4): e0297749 doi: 10.1371/journal.pone.0297749
|
72 |
Jonghyeob Lee, Emily R. Snyder, Yinghua Liu, Xueying Gu, Jing Wang, Brittany M. Flowers, Yoo Jung Kim, Sangbin Park, Gregory L. Szot, Ralph H. Hruban, Teri A. Longacre, Seung K. Kim. Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells. Nature Communications 2017; 8(1) doi: 10.1038/ncomms14686
|
73 |
Na Li, Fan Yang, Dong-Yan Liu, Jin-Tao Guo, Nan Ge, Si-Yu Sun. Scoparone inhibits pancreatic cancer through PI3K/Akt signaling pathway. World Journal of Gastrointestinal Oncology 2021; 13(9): 1164-1183 doi: 10.4251/wjgo.v13.i9.1164
|